Equity Mates Investing Podcast cover image

$100 million sign on bonuses, will Ren sell Novo Nordisk & how to find a great buyers agent?

Equity Mates Investing Podcast

00:00

Exploring the Future of Brain-Computer Interfaces and Novo Nordisk's Market Challenges

This chapter explores the implications of brain-computer interfaces on societal inequality and labor markets, emphasizing the pressure to embrace new technologies. It also critically examines Novo Nordisk's weight loss drug Ozempic, highlighting a missed patent fee that jeopardizes its market standing.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app